Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients

By Zambetti M.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 255-260

Springer Publishing Company

Access to resources Recommend Favorite

Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer

By Zambelli A.   Robustelli della Cuna F.S.   Ponchio L.   Ucci G.   Prada G.A.D.   Robustelli della Cuna G.  

Breast Cancer Research and Treatment, Vol. 61, Iss. 3, 2000-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

An EORTC-IDBBC phase I study of gemcitabine and continuous infusion 5-fluorouracil in patients with metastatic breast cancer resistant to anthracyclines or pre-treated with both anthracyclines and taxanes

By Awada A.   Biganzoli L.   Cufer T.   Beex L.   Lohrisch C.   Batter V.   Hamilton A.   Nooij M.   Piccart M.  

European Journal of Cancer, Vol. 38, Iss. 6, 2002-01 ,pp. : 773-778

Elsevier

Access to resources Recommend Favorite

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study

By                                    

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2137-2142

Spandidos Publications

Access to resources Recommend Favorite

Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies

By Roché Henri  

Breast Cancer Research and Treatment, Vol. 125, Iss. 3, 2011-02 ,pp. : 755-765

Springer Publishing Company

Access to resources Recommend Favorite